# SpectaCell spins out of imec with €6M for immune therapy

> SpectaCell, a Ghent- and Leiden-based startup, gets €6 million to speed up immune therapy development using semiconductor tech.
- Title: SpectaCell spins out of imec with €6M for immune therapy
- Summary: SpectaCell, a Ghent- and Leiden-based startup, gets €6 million to speed up immune therapy development using semiconductor tech. SpectaCell, spun from imec…
- Keywords: spectacell, imec, ghent university, vib, flanders future tech fund, innovationquarter capital, qbic, immunotherapy, cell analysis platform, pharmaceutical firms, biotechs, drug development
- Source: Dealroom — https://dealroom.co/news/163706-spectacell-spins-out-of-imec-with-6m-to-speed-up-immune-therapy-developm
- Published: 2026-10-18T20:38:13+00:00
- Read time: 1 min
- Topics: spectacell, imec, ghent university, vib, flanders future tech fund, innovationquarter capital, qbic, immunotherapy, cell analysis platform, pharmaceutical firms, biotechs, drug development
## SpectaCell spins out of imec
SpectaCell, a Ghent- and Leiden-based startup, launched with €6 million seed financing led by imec.xpand.
## Immune therapy platform development
The company builds a cell analysis platform to measure treatment effects on individual cells for cancer and immune diseases.
## €6m seed funding for commercialisation
SpectaCell uses the seed money to fund further development and commercialisation with biopharma partners.

> Researchers need to know much earlier which candidates deserve further investment and why
## Key takeaway

SpectaCell, spun from imec, secured €6 million seed funding to advance immune therapy research with semiconductor-based cell analysis.